Fulgent Genetics share price logo

Fulgent Genetics

NASDAQ: FLGT

Small Cap

$20.20

+0.47

(+2.38%)

as on

Fulgent Genetics Stock Performance

as on September 9, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $19.44
    $20.18
    downward going graph

    3.76%

    Downside

    -0.10%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $13.46
    $31.04
    downward going graph

    33.37%

    Downside

    53.66%

    Upside

    downward going graph

Fulgent Genetics share price movements today

Previous Close
$19.73
Open
$19.57
Volume
394.6K
Market Cap
$542.9M
Day's Low - High
$19.44 - $20.18
52 Week Low - High
$13.46 - $31.04

Fulgent Genetics Historical Returns

1 Month Return
+ 3.08 %
3 Month Return
+ 3.03 %
1 Year Return
-10.11 %
3 Year Return
-37.76 %
5 Year Return
-78.08 %

Fulgent Genetics Stock Fundamentals & Key Indicators

Check Fulgent Genetics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$542.9M

EPS (TTM)

-2.82

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.99%

PE Ratio (TTM)

-7

Industry PE ratio

-14.14

PEG Ratio

0.12360510993008768

EBITDA

-65.0M

Revenue (TTM)

323.9M

Profit Margin

35.58%

Return On Equity TTM

-7.87%

Fulgent Genetics Stock Valuation

Track how Fulgent Genetics P/E has moved over time to understand its valuation trends.

Fulgent Genetics in the last 5 years

  • Overview

  • Trends

Lowest (-13.34x)

December 31, 2025

Industry (-14.14x)

December 31, 2025

Today (-13.34x)

December 31, 2025

Highest (6.25x)

December 31, 2022

LowHigh

Today’s Price to Earnings Ratio: -13.34x

Fulgent Genetics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Fulgent Genetics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Fulgent Genetics image
Fulgent Genetics
BUY$542.9M-78.08%-735.58%NA
Natera image
Natera
BUY$47.3B167.95%-228.5165.30%NA
IQVIA Holdings image
IQVIA Holdings
BUY$44.1B1.26%32.9426.23%NA
Thermo Fisher image
Thermo Fisher
BUY$228.2B6.19%3240.37%0.3%
Danaher image
Danaher
BUY$146.0B-37.07%36.7558.51%0.69%

Stock Returns calculator for Fulgent Genetics Stock including INR - Dollar returns

The Fulgent Genetics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Fulgent Genetics investment value today

Current value as on today

₹99,179

Returns

-₹821

(-0.82%)

Returns from Fulgent Genetics Stock

-₹7,973 (-7.97%)

Dollar Impact

₹7,151 (+7.15%)

Analyst Recommendation on Fulgent Genetics Stock

Based on 1 analysts

BUY

0.00%

Buy

100.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for Fulgent Genetics. Average target price of $19

Fulgent Genetics Share Price Target

Get share price movements and forecasts by analysts on Fulgent Genetics.

What analysts predicted

-6.32%DOWNSIDE

Target Price

$19

Current Price

$20.2

Analyzed by

1 Analysts

Target

$19.00

Fulgent Genetics target price $19, a slight downside of -6.32% compared to current price of $20.2. According to 1 analysts rating.

Indian Investors' Interest in Fulgent Genetics Stock

Search interest for Fulgent Genetics Stock has increased by 233% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:233% versus previous 30 day period

Fulgent Genetics Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
64
71
71
76
73
81
84
83
71
85
Gross Profit
22
26
26
31
28
34
35
32
21
25
Operating Income
-21
-18
-17
-16
-19
-19
-15
-36
-34
-33
EBITDA
-7
-5
-12
-1
-5
-15
0
-23
-19
-21
Interest Expense
-
-
0
0
0
0
0
0
0
0
Depreciation
6
6
5
6
5
6
6
6
6
7
Income Before Tax
-14
-11
-18
-8
-11
-21
-6
-29
-25
-29
Income Tax Expense
0
-2
-3
-1
0
-2
0
-5
0
0
Net Income
-13
-8
-14
-5
-11
-18
-6
-23
-24
-29
Net Profit Margin
34.28%
37.30%
37.32%
41.79%
38.59%
42.10%
42.24%
39.10%
30.21%
30.07%

Fulgent Genetics Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
18
21
32
421
992
618
289
283
322
Gross Profit
10
10
18
331
777
366
104
107
130
Operating Income
-3
-5
0
290
675
178
-195
-73
-91
EBITDA
-1
-2
1
293
692
217
-147
-26
-45
Interest Expense
-
-
-
-
-
1
0
0
0
Depreciation
1
2
2
2
11
32
26
24
24
Income Before Tax
-3
-4
0
286
681
184
-174
-51
-70
Income Tax Expense
-1
0
0
72
174
42
1
-8
-8
Net Income
-2
-5
0
214
507
143
-167
-42
-60
Net Profit Margin
54.35%
49.94%
56.63%
78.70%
78.29%
59.28%
36.12%
37.82%
40.56%

Fulgent Genetics Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-13
-9
-14
-6
-11
-19
-6
-23
-24
-30
Operating Cash Flow
7
4
-15
25
-4
-30
11
-78
7
-23
Investing Cash Flow
-47
7
8
-27
27
53
19
11
10
50
Financing Cash Flow
-2
-1
0
0
-11
-2
0
0
-44
-24
Change in Cash
-42
10
-6
-2
12
20
29
-67
-26
2

Fulgent Genetics Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-2
-5
0
214
506
141
-167
-43
-61
Operating Cash Flow
1
0
5
140
538
253
27
21
-101
Investing Cash Flow
-2
0
-29
-326
-546
-261
38
-58
111
Financing Cash Flow
0
0
28
261
85
-77
-47
-4
-14
Change in Cash
-1
0
5
75
77
-85
17
-42
-4

Mutual Funds that own Fulgent Genetics Stock

Check out the Mutual Funds with significant holdings in Fulgent Genetics.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
3.115187%
857153
NORTHERN LIGHTS FUND TRUST II
1.687221%
464244
COLUMBIA FUNDS SERIES TRUST I
1.353352%
372379
Columbia Funds Series Trust I
1.261403%
347079
DFA INVESTMENT DIMENSIONS GROUP INC
1.16244%
319849
See all

Global Institutional Holdings in Fulgent Genetics

Funds
Holdings
Vanguard
3.47%
iShares
3.13%
Dimensional
0.95%
Schwab
0.92%
SPDR
0.58%
See all

Insights on Fulgent Genetics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 71.13M → 85.38M (in $), with an average increase of 16.7% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, FLGT stock has moved up by 35.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Natera, Inc. Common Stock has given 498.0% return, outperforming this stock by 532.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Natera, Inc. Common Stock has given 83.8% return, outperforming this stock by 93.3%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 4 quarters, -6.60M → -29.53M (in $), with an average decrease of 93.1% per quarter

About Fulgent Genetics

Fulgent Genetics, Inc. provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services; and sequencer services related to hereditary cancer, reproductive health, and other diseases. Its therapeutic development solutions focus on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform to enhance the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. The company operates picture genetics platform, which includes gene probes, data suppression and comparison algorithms, adaptive learning software, and proprietary laboratory information management systems that helps customers to identify health markers in their personal DNA. It serves insurance, hospitals, medical institutions, other laboratories, governmental bodies, payors, large corporations, and patients. Fulgent Genetics, Inc. was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. The company was founded in 2011 and is headquartered in El Monte, California.
OrganisationFulgent Genetics
Headquarters4399 Santa Anita Avenue, El Monte, CA, United States, 91731
IndustryDiagnostics & Research
CEOMr. Ming Hsieh
E-voting on sharesClick here to vote

Key Management of Fulgent Genetics

Name

Title

Ms. Ellen Tsui

Vice President of Human Resources

Mr. Ming Hsieh

Chairman & CEO

Mr. Jian Xie

COO & President

Dr. Hanlin Gao D.A.B.M.G., FACMG, M.D., Ph.D.

Chief Scientific Officer & Lab Director

Ms. Natalie Prescott CIPM, CIPP

General Counsel & Chief Privacy Officer

Mr. Elias Nyankojo

Chief Information Security Officer

Mr. Paul Kim CPA

Chief Financial Officer

Ms. Doreen Ng

Vice President of Operations & Compliance

Mr. Jakub Sram

Vice President of Business Development & Sales

Mr. Brandon Perthuis

Chief Commercial Officer

FAQs

What is Fulgent Genetics share price today?

Fulgent Genetics share price today is $20.20 as on at the close of the market. Fulgent Genetics share today touched a day high of $20.18 and a low of $19.44.

What is the 52 week high and 52 week low for Fulgent Genetics share?

Fulgent Genetics share touched a 52 week high of $31.04 on and a 52 week low of $13.46 on . Fulgent Genetics stock price today i.e. is closed at $20.20,which is 34.92% down from its 52 week high and 50.07% up from its 52 week low.

What is Fulgent Genetics's market capitalisation today?

Fulgent Genetics market capitalisation is $0.00T as on .

How to invest in Fulgent Genetics Stock (FLGT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Fulgent Genetics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Fulgent Genetics Shares that will get you 0.0743 shares as per Fulgent Genetics share price of $20.20 per share as on September 9, 2026 at 8:46 am IST.

What is the minimum amount required to buy Fulgent Genetics Stock (FLGT) from India?

Indian investors can start investing in Fulgent Genetics (FLGT) shares with as little as ₹94.8175 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹948.17 in Fulgent Genetics stock (as per the Rupee-Dollar exchange rate as on ). Based on Fulgent Genetics share’s latest price of $20.20 as on September 9, 2026 at 8:46 am IST, you will get 0.4950 shares of Fulgent Genetics. Learn more about fractional shares .

What are the returns that Fulgent Genetics has given to Indian investors in the last 5 years?

Fulgent Genetics stock has given -78.08% share price returns and 28.04% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?